Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574015 · ClinicalTrials.gov registry record · Phase 4
The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache
A Phase 4 study of Toothache, sponsored by Albany Medical College.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT00574015: Completed Phase 4 study of Toothache, sponsored by Albany Medical College.
NCT00574015 is a Phase 4 study of Toothache that has completed, run by Albany Medical College. The registered enrollment target is 18 participants, below the 159-participant average among 3 other Toothache trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00574015, a Phase 4 study of Toothache, has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the degree of pain control provided by two techniques for persons with toothache in an emergency department. The two techniques include; * standard oral narcotic pain medication * numbing the tooth with local anesthetic by needle injection
Conditions Studied
Interventions
- DRUG hydrocodone/acetaminophen
- DRUG bupivacaine (supraperiosteal nerve block)
Study Locations (1)
New York
- Albany Medical Center Hospital - Albany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-12 |
| Est. Completion | 2013-01 |
| Phase | Phase 4 |
What the finished NCT00574015 record still lists
NCT00574015 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 159-participant average among 3 other Toothache trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Toothache appearing as the primary indexed condition, and to 2 interventions - of which hydrocodone/acetaminophen is the first listed.
NCT00574015 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00574015 about?
NCT00574015 is a clinical study titled "The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache". This study will compare the degree of pain control provided by two techniques for persons with toothache in an emergency department. The two techniques include; * standard oral narcotic pain medication * numbing the tooth with local anesthetic by needle injection
What is the current status of trial NCT00574015?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2007-12. Estimated completion is 2013-01.
What conditions does trial NCT00574015 study?
This clinical trial studies the following conditions: Toothache.
What interventions are being tested in trial NCT00574015?
The interventions under investigation include: hydrocodone/acetaminophen (DRUG), bupivacaine (supraperiosteal nerve block) (DRUG).
Who is sponsoring clinical trial NCT00574015?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00574015 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Toothache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia